Pramipexole (Prami), 12 mg (0.2 mg/60 capsules)
$40.99
Pramipexole is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family. Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled… CAS: 104632-26-0 | Formula: C10H17N3S | Content: 12 mg (0.2 mg per capsule) | Research use only | Third-party lab tested.
Buy Pramipexole (Prami), 12 mg (0.2 mg/60 capsules) – Swiss Chems USA
Pramipexole (Prami), 12 mg (0.2 mg/60 capsules) — Research Overview
Pramipexole is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family. Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled receptor activation mechanisms, intracellular cAMP regulation, and receptor-ligand dynamics. Its receptor selectivity profile makes it a valuable research tool for studies of D2/D3 receptor pharmacology, dopaminergic signaling networks, receptor subtype selectivity, signal transduction mechanisms, and comparative investigations of dopamine receptor-mediated regulatory pathways.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Pramipexole (Prami), 12 mg (0.2 mg/60 capsules) Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C10H17N3S |
| Synonyms | Mirapex (trade name), Sifrol (trade name), PPX, (S)-Pramipexole |
| Molar Mass | 211.33 g/mol |
| CAS Number | 104632-26-0 |
| PubChem CID | 119570 |
| Total Compound Content | 12 mg (0.2 mg per capsule) |
| Shelf Life | 36 months |
Pramipexole (Prami), 12 mg (0.2 mg/60 capsules) Research Applications
Pramipexole ((S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine) is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family. Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled receptor activation mechanisms, intracellular cAMP regulation, and receptor-ligand dynamics. Its high D3 receptor selectivity makes it a valuable research tool for studies of D2/D3 receptor pharmacology, receptor subtype differentiation, dopaminergic signaling networks, signal transduction mechanisms, and comparative investigations of dopamine receptor-mediated regulatory pathways. Supplied in 0.2 mg capsules. Independently third-party HPLC-tested; COA available per batch.
Pramipexole (Prami), 12 mg (0.2 mg/60 capsules) Frequently Asked Questions
What is pramipexole’s receptor selectivity profile and why is D3 selectivity research-relevant?
Pramipexole exhibits preferential affinity for D3 receptors within the D2-like dopamine receptor family, with additional activity at D2 and D4 receptor subtypes. This receptor selectivity profile makes it a valuable research tool for investigating D3 receptor pharmacology, receptor subtype differentiation, dopaminergic signaling mechanisms, and comparative studies of D2-like receptor function. Experimental investigations frequently utilize pramipexole to examine receptor-ligand interactions, signal transduction pathways, and subtype-specific dopamine receptor regulation.
How is pramipexole used in dopaminergic signaling research?
Pramipexole is widely used as a selective dopaminergic probe for studies of D2-like receptor activation, G protein-coupled receptor signaling, intracellular cAMP regulation, and dopamine receptor-mediated communication networks. Its well-characterized receptor profile allows researchers to investigate the molecular and signaling consequences of D3-preferring receptor activation and compare these effects with broader dopaminergic signaling mechanisms.
What makes pramipexole useful for dopamine receptor pharmacology studies?
Pramipexole’s high affinity for D3 receptors and established activity at D2-like receptor subtypes make it a valuable reference compound for investigations of receptor selectivity, dopamine receptor signaling pathways, ligand-receptor dynamics, and GPCR-mediated regulatory mechanisms. These characteristics support its use in mechanistic studies of dopaminergic pharmacology and comparative analyses of D2-family receptor function.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 3 lbs |
|---|
Related products
BPC-157 with Arginine Salt
Price range: $39.99 through $599.50
Clomiphene, 1500mg (25mg/capsule)
Original price was: $79.95.$69.95Current price is: $69.95.
Reviews
There are no reviews yet.